Dr. Lal Pathlabs Share Price
Sector: Healthcare Facilities
2820.75 +40.85 (1.47%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
2752.25
Today’s High
2853.00
52 Week Low
2295.10
52 Week High
3645.00
2823.80 +57.70 (2.09%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
2755.00
Today’s High
2853.90
52 Week Low
2293.55
52 Week High
3653.95
Key Metrics
- Market Cap (In Cr) 23560.98
- Beta 1
- Div. Yield (%) 0.87
- P/B 10.61
- TTM P/E 42.39
- Peg Ratio 9.12
- Sector P/E 23.63
- D/E 0
- Open Price 2752.25
- Prev Close 2779.9
Dr. Lal Pathlabs Analysis
Price Analysis
-
1 Week-3.41%
-
3 Months17.72%
-
6 Month-8.35%
-
YTD-7.81%
-
1 Year4.47%
Risk Meter
- 30% Low risk
- 30% Moderate risk
- 30% Balanced Risk
- 30% High risk
- 30% Extreme risk
Recos
- Strong Sell
- Sell
- Hold
- Buy
- Strong Buy
Analysts' Views
- Ratings
- Current
- 1 W Ago
- 1 M Ago
- 3 M Ago
- Strong Buy
- 2
- 2
- 2
- 2
- Buy
- 11
- 11
- 11
- 10
- Hold
- 3
- 3
- 3
- 2
- Sell
- 3
- 3
- 3
- 3
- Strong Sell
- 2
- 2
- 3
- 3
- Total
- 21
- 21
- 22
- 20
Dr. Lal Pathlabs News
Stocks to trade today: Trade Brains Portal recommends two stocks for 3 June
6 min read . 07:00 AM ISTRecommended stocks to buy today: Top stock picks by market experts for 3 June
7 min read . 07:00 AM ISTDr Lal PathLabs feels margin heat as it chases growth, long-term outlook strong
5 min read . 01 May 2025Dividend stocks 2025: Shree Cement, Coromandel, Dr Lal trade ex-date today
1 min read . 05 Feb 2025Dr. Lal Pathlabs Financials
- INCOME
- BALANCE SHEET
- Cashflow
- Period
- 2025
- Total Revenue
- 2461.4
- Selling/ General/ Admin Expenses Total
- 824.1
- Depreciation/ Amortization
- 141.9
- Other Operating Expenses Total
- 460.3
- Total Operating Expense
- 1907.8
- Operating Income
- 553.6
- Net Income Before Taxes
- 624.7
- Net Income
- 487.1
- Diluted Normalized EPS
- 48.4
- Period
- 2025
- Total Assets
- 2716.8
- Total Liabilities
- 544.1
- Total Equity
- 2172.7
- Tangible Book Valueper Share Common Eq
- 164.75
- Period
- 2025
- Cashfrom Operating Activities
- 568.8
- Cashfrom Investing Activities
- -303.1
- Cashfrom Financing Activities
- -334
- Net Changein Cash
- -68.3
- Period
- 2024
- Total Revenue
- 2226.64
- Selling/ General/ Admin Expenses Total
- 1095.38
- Depreciation/ Amortization
- 143.34
- Other Operating Expenses Total
- 41.93
- Total Operating Expense
- 1758.49
- Operating Income
- 468.15
- Net Income Before Taxes
- 505.45
- Net Income
- 357.74
- Diluted Normalized EPS
- 43
- Period
- 2024
- Total Assets
- 2455.96
- Total Liabilities
- 606.68
- Total Equity
- 1849.28
- Tangible Book Valueper Share Common Eq
- 119.79
- Period
- 2024
- Cashfrom Operating Activities
- 535.33
- Cashfrom Investing Activities
- -24.27
- Cashfrom Financing Activities
- -413.86
- Net Changein Cash
- 97.2
- Period
- 2023
- Total Revenue
- 2016.88
- Selling/ General/ Admin Expenses Total
- 1016.91
- Depreciation/ Amortization
- 150.19
- Other Operating Expenses Total
- 37.08
- Total Operating Expense
- 1677.24
- Operating Income
- 339.64
- Net Income Before Taxes
- 343.83
- Net Income
- 238.85
- Diluted Normalized EPS
- 28.67
- Period
- 2023
- Total Assets
- 2385.56
- Total Liabilities
- 719.26
- Total Equity
- 1666.3
- Tangible Book Valueper Share Common Eq
- 91.66
- Period
- 2023
- Cashfrom Operating Activities
- 456.03
- Cashfrom Investing Activities
- -287.31
- Cashfrom Financing Activities
- -283.18
- Net Changein Cash
- -114.46
- Period
- 2022
- Total Revenue
- 2087.41
- Selling/ General/ Admin Expenses Total
- 962.59
- Depreciation/ Amortization
- 108.11
- Other Operating Expenses Total
- 37.81
- Total Operating Expense
- 1632.88
- Operating Income
- 454.53
- Net Income Before Taxes
- 474.98
- Net Income
- 344.83
- Diluted Normalized EPS
- 41.63
- Period
- 2022
- Total Assets
- 2346.75
- Total Liabilities
- 845.14
- Total Equity
- 1501.61
- Tangible Book Valueper Share Common Eq
- 66.17
- Period
- 2022
- Cashfrom Operating Activities
- 446.69
- Cashfrom Investing Activities
- -449.25
- Cashfrom Financing Activities
- 136.45
- Net Changein Cash
- 133.9
- Period
- 2021
- Total Revenue
- 1581.27
- Selling/ General/ Admin Expenses Total
- 699.12
- Depreciation/ Amortization
- 77.2
- Other Operating Expenses Total
- 29.81
- Total Operating Expense
- 1222.01
- Operating Income
- 359.25
- Net Income Before Taxes
- 394.41
- Net Income
- 291.62
- Diluted Normalized EPS
- 35.26
- Period
- 2021
- Total Assets
- 1661.33
- Total Liabilities
- 416.27
- Total Equity
- 1245.06
- Tangible Book Valueper Share Common Eq
- 133.16
- Period
- 2021
- Cashfrom Operating Activities
- 398.15
- Cashfrom Investing Activities
- -212.02
- Cashfrom Financing Activities
- -138.56
- Net Changein Cash
- 47.58
- Period
- 2020
- Total Revenue
- 1330.36
- Selling/ General/ Admin Expenses Total
- 643.15
- Depreciation/ Amortization
- 72.81
- Other Operating Expenses Total
- 28.18
- Total Operating Expense
- 1059.59
- Operating Income
- 270.77
- Net Income Before Taxes
- 310.5
- Net Income
- 225.94
- Diluted Normalized EPS
- 27.36
- Period
- 2020
- Total Assets
- 1374.31
- Total Liabilities
- 341.5
- Total Equity
- 1032.81
- Tangible Book Valueper Share Common Eq
- 110.4
- Period
- 2020
- Cashfrom Operating Activities
- 283.89
- Cashfrom Investing Activities
- -26.11
- Cashfrom Financing Activities
- -190.45
- Net Changein Cash
- 67.33
- Period
- 2025-03-31
- Total Revenue
- 602.6
- Selling/ General/ Admin Expenses Total
- 193
- Depreciation/ Amortization
- 36.4
- Other Operating Expenses Total
- 122.8
- Total Operating Expense
- 470
- Operating Income
- 132.6
- Net Income Before Taxes
- 153.4
- Net Income
- 154.8
- Diluted Normalized EPS
- 18.54
- Period
- 2025-03-31
- Total Assets
- 2716.8
- Total Liabilities
- 544.1
- Total Equity
- 2172.7
- Tangible Book Valueper Share Common Eq
- 164.75
- Period
- 2025-03-31
- Cashfrom Operating Activities
- 568.8
- Cashfrom Investing Activities
- -303.1
- Cashfrom Financing Activities
- -334
- Net Changein Cash
- -68.3
- Period
- 2024-12-31
- Total Revenue
- 596.7
- Selling/ General/ Admin Expenses Total
- 213.1
- Depreciation/ Amortization
- 35.5
- Other Operating Expenses Total
- 112.6
- Total Operating Expense
- 478.2
- Operating Income
- 118.5
- Net Income Before Taxes
- 138.3
- Net Income
- 96.7
- Diluted Normalized EPS
- 11.58
- Period
- 2024-12-31
- Period
- 2024-12-31
- Period
- 2024-09-30
- Total Revenue
- 660.2
- Selling/ General/ Admin Expenses Total
- 217.7
- Depreciation/ Amortization
- 35.3
- Other Operating Expenses Total
- 112.7
- Total Operating Expense
- 493
- Operating Income
- 167.2
- Net Income Before Taxes
- 183.1
- Net Income
- 129.2
- Diluted Normalized EPS
- 15.48
- Period
- 2024-09-30
- Total Assets
- 2597.5
- Total Liabilities
- 595.9
- Total Equity
- 2001.6
- Tangible Book Valueper Share Common Eq
- 140.97
- Period
- 2024-09-30
- Cashfrom Operating Activities
- 306.6
- Cashfrom Investing Activities
- -390.9
- Cashfrom Financing Activities
- -169.8
- Net Changein Cash
- -254.1
- Period
- 2024-06-30
- Total Revenue
- 601.9
- Selling/ General/ Admin Expenses Total
- 200.3
- Depreciation/ Amortization
- 34.7
- Other Operating Expenses Total
- 112.2
- Total Operating Expense
- 466.6
- Operating Income
- 135.3
- Net Income Before Taxes
- 149.9
- Net Income
- 106.4
- Diluted Normalized EPS
- 12.76
- Period
- 2024-06-30
- Period
- 2024-06-30
- Period
- 2024-03-31
- Total Revenue
- 545.44
- Selling/ General/ Admin Expenses Total
- 181.08
- Depreciation/ Amortization
- 36.6
- Other Operating Expenses Total
- 110.8
- Total Operating Expense
- 437.4
- Operating Income
- 108.05
- Net Income Before Taxes
- 119.85
- Net Income
- 84.54
- Diluted Normalized EPS
- 10.17
- Period
- 2024-03-31
- Total Assets
- 2455.96
- Total Liabilities
- 606.68
- Total Equity
- 1849.28
- Tangible Book Valueper Share Common Eq
- 119.79
- Period
- 2024-03-31
- Cashfrom Operating Activities
- 535.33
- Cashfrom Investing Activities
- -24.27
- Cashfrom Financing Activities
- -413.86
- Net Changein Cash
- 97.2
Forecast
Income Sheet (In Cr)
Net Income Vs Revenue
Returns Metrics (In Cr)
ROA Vs ROE
Forecast
Balance Sheet
Asset vs Liability
Forecast
Cash Flow
Operating vs Investing
Dr. Lal Pathlabs Technical
Moving Average
SMA
- 5 Day2832.35
- 10 Day2828.38
- 20 Day2811.94
- 50 Day2699.05
- 100 Day2704.99
- 300 Day2955.81
Dr. Lal Pathlabs Peers
- Price
- Ratio
- Name
- Latest Price
- Change
- % Change
- 52W High
- 52W Low
- Mkt. Cap
- Aster Dm Healthcare
- 551.95
- -1.35
- -0.24
- 609
- 312.25
- 27615.02
- Krishna Instit Of Medical Scienc
- 677
- 7.4
- 1.11
- 707.5
- 350.02
- 27061.71
- Dr. Lal Pathlabs
- 2820.75
- 40.85
- 1.47
- 3645
- 2295.1
- 23560.98
- Rainbow Childrens Medicare
- 1401.35
- 24.1
- 1.75
- 1708.5
- 1079.25
- 14230.94
- Vijaya Diagnostic Centre
- 961.5
- -0.9
- -0.09
- 1276.75
- 725.4
- 9929.37
- Name
- P/E (X)
- P/B (X)
- ROE %
- OPM
- Aster Dm Healthcare
- 81.44
- 8.13
- 6.16
- 4.98
- Krishna Instit Of Medical Scienc
- 72.72
- 12.81
- 21.99
- 15.55
- Dr. Lal Pathlabs
- 57.57
- 10.69
- 21.87
- 16.8
- Rainbow Childrens Medicare
- 58.83
- 9.7
- 19.73
- 15.21
- Vijaya Diagnostic Centre
- 68.33
- 12.34
- 21.09
- 21.54
Dr. Lal Pathlabs Shareholding
Shareholding Pattern
Shareholding Trend
Shareholding(%) v/s Date
Corporate Actions
- Board Meeting
- AGM
- Dividends
- Bonus
- Split
- Rights
- Meeting Date
- Purpose
- 25-Apr-25
- Audited Results & Final Dividend
- 30-Jan-25
- Quarterly Results, Dividend & Others
- 23-Oct-24
- Quarterly Results & Interim Dividend
- 07-Aug-24
- Quarterly Results & Interim Dividend
- 10-May-24
- Audited Results & Final Dividend
- 01-Feb-24
- Quarterly Results & Interim Dividend
- 02-Nov-23
- Quarterly Results
- 27-Jul-23
- Quarterly Results & Interim Dividend
- 11-May-23
- Audited Results & Final Dividend
- 02-Feb-23
- Quarterly Results
- Meeting Date
- Announced on
- Purpose
- 28-Jun-25
- 25-Apr-25
- AGM
- 11-Mar-25
- 07-Feb-25
- POM
- 29-Jun-24
- 10-May-24
- AGM
- 12-Sept-23
- 27-Jul-23
- AGM
- 12-Mar-23
- 08-Feb-23
- POM
- 30-Jun-22
- 17-May-22
- AGM
- 29-Jul-21
- 21-May-21
- AGM
- Announced on
- Record Date
- Ex-Dividend
- Dividend Value
- 25-Apr-25
- 06-Jun-25
- 06-Jun-25
- 6
- 30-Jan-25
- 05-Feb-25
- 05-Feb-25
- 6
- 23-Oct-24
- 05-Nov-24
- 05-Nov-24
- 6
- 07-Aug-24
- 20-Aug-24
- 20-Aug-24
- 6
- 10-May-24
- 10-Jun-24
- 10-Jun-24
- 6
- 01-Feb-24
- 13-Feb-24
- 13-Feb-24
- 12
- 11-May-23
- 11-Aug-23
- 11-Aug-23
- 6
- 27-Jul-23
- 11-Aug-23
- 11-Aug-23
- 6
- 28-Jul-22
- 09-Aug-22
- 05-Aug-22
- 6
- 17-May-22
- 23-Jun-22
- 22-Jun-22
- 6


